Literature DB >> 4267967

Changes in brain concentration of biogenic amines and the antinociceptive effect of morphine in rats.

K Reinhold, J Bläsig, A Herz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4267967     DOI： 10.1007/bf00501864

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  22 in total

1.  Studies on the relationship between 5-hydroxytryptamine turnover in brain and tolerance and physical dependence in mice.

Authors:  Y Maruyama; G Hayashi; S E Smits; A E Takemori
Journal:  J Pharmacol Exp Ther       Date:  1971-07       Impact factor: 4.030

2.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

3.  An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues.

Authors:  N E Andén; T Magnusson
Journal:  Acta Physiol Scand       Date:  1967 Jan-Feb

4.  Potentiation and reduction of the analgesia of morphine in the rat by pargyline.

Authors:  S Y Yeh; C L Mitchell
Journal:  J Pharmacol Exp Ther       Date:  1971-12       Impact factor: 4.030

5.  Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor.

Authors:  S S Tenen
Journal:  Psychopharmacologia       Date:  1968

6.  Toxicologic studies with alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.

Authors:  K E Moore; P F Wright; J K Bert
Journal:  J Pharmacol Exp Ther       Date:  1967-03       Impact factor: 4.030

7.  Localization of catecholamine uptake in rat brain after intraventricular injection.

Authors:  K Fuxe; U Ungerstedt
Journal:  Life Sci       Date:  1966-10       Impact factor: 5.037

8.  Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.

Authors:  H Corrodi; K Fuxe; T Hökfelt
Journal:  Life Sci       Date:  1966-04       Impact factor: 5.037

9.  Effects of alpha-methyl-p-tyrosine, p-chlorophenylalanine, l-beta-(3,4-dihydroxyphenyl)alanine, 5-hydroxytryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse.

Authors:  C T Major; B J Pleuvry
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

10.  Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat.

Authors:  C G Sparkes; P S Spencer
Journal:  Br J Pharmacol       Date:  1971-06       Impact factor: 8.739
View more
  6 in total

Review 1.  The functional pool of brain catecholamines: its size and turnover rate.

Authors:  R Papeschi
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

2.  Effects of narcotic analgesics on the uptake and release of 5-hydroxytryptamine in rat synaptosomal preparations.

Authors:  T Mennini; R Pataccini; R Samanin
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

3.  Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices.

Authors:  H Montel; K Starke; F Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Effects of depletion of brain catecholamines during the development of morphine dependence on precipitated withdrawal in rats.

Authors:  J Bläsig; A Herz; C Gramsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

5.  Analgesic effect of etorphine in rats with selective depletions of brain monoamines.

Authors:  F Miranda; G Candelaresi; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

6.  Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.

Authors:  G Paalzow; L Paalzow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.